Dr. Akshay Amaraneni, MD

Dr. Amaraneni practices at University of Arizona in Tucson, Arizona.

Dr. Amaraneni's NPI, 1306285267, was assigned on June 24, 2013. Dr. Amaraneni holds Arizona license 52433.

Dr. Amaraneni's primary practice is University of Arizona, at 1501 N Campbell Ave, Tucson, AZ 85724 in Pima County. The practice phone is (520) 626-2761.

Dr. Amaraneni's primary practice is University of Arizona in Tucson, Arizona. Dr. Amaraneni is also affiliated with Banner - University Medical Center Tucson. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Amaraneni to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amaraneni practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Amaraneni's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Amaraneni's licenses on file in 2 states: Arizona and Michigan.

CMS data shows 440 Medicare services from Dr. Amaraneni across 8 procedure codes in 2024, for 211 Medicare patients. Medicare paid $35,576 for them.

CMS counts 211 Medicare patients who saw Dr. Amaraneni in 2024. The largest group is 75 to 84, with 88 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amaraneni's median patient age at 66, with 52% women.

In 2024, Dr. Amaraneni wrote 507 Medicare Part D claims for 101 patients. 55% of them were for generic drugs. CMS names the drug for 323 of them, across 14 drugs with 11 or more claims each, at $1,947,495 in total drug cost. In 2023, CMS named 193 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Amaraneni for performance year 2024, reported through an alternative payment model (APM). Dr. Amaraneni accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Amaraneni, published from 2011 to 2023. 2023 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Association Learning and Cognitive Dysfunction. Dr. Amaraneni has published most often in IDCases. Dr. Amaraneni's most frequent co-authors are Sreenivasa R. Chandana, MD, Faisal Akbar, MD and Faiz Anwer, MD.

CMS Open Payments shows 481 general payments to Dr. Amaraneni from 64 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 36% of the total. Rigel Pharmaceuticals, Inc. paid the most, $42,702.